Literature DB >> 24359474

Genetic evaluation and application of posterior cranial fossa traits as endophenotypes for Chiari type I malformation.

Christina A Markunas1, David S Enterline, Kaitlyn Dunlap, Karen Soldano, Heidi Cope, Jeffrey Stajich, Gerald Grant, Herbert Fuchs, Simon G Gregory, Allison E Ashley-Koch.   

Abstract

Chiari Type I Malformation (CMI) is characterized by herniation of the cerebellar tonsils through the base of the skull. Although cerebellar tonsillar herniation (CTH) is hypothesized to result from an underdeveloped posterior cranial fossa (PF), patients are frequently diagnosed by the extent of CTH without cranial morphometric assessment. We recently completed the largest CMI whole genome qualitative linkage screen to date. Despite an initial lack of statistical evidence, stratified analyses using clinical criteria to reduce heterogeneity resulted in a striking increase in evidence for linkage. The present study focused on the use of cranial base morphometrics to further dissect this heterogeneity and increase power to identify disease genes. We characterized the genetic contribution for a series of PF traits and evaluated the use of heritable, disease-relevant PF traits in ordered subset analysis (OSA). Consistent with a genetic hypothesis for CMI, much of the PF morphology was found to be heritable and multiple genomic regions were strongly implicated from OSA, including regions on Chromosomes 1 (LOD = 3.07, p = 3 × 10(-3) ) and 22 (LOD = 3.45, p = 6 × 10(-5) ) containing several candidates warranting further investigation. This study underscores the genetic heterogeneity of CMI and the utility of PF traits in CMI genetic studies.
© 2013 John Wiley & Sons Ltd/University College London.

Entities:  

Keywords:  Chiari Type I Malformation; Posterior cranial fossa; endophenotypes; heritability; ordered subset analysis

Mesh:

Year:  2013        PMID: 24359474      PMCID: PMC4041368          DOI: 10.1111/ahg.12041

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  32 in total

1.  Chiari I malformation redefined: clinical and radiographic findings for 364 symptomatic patients.

Authors:  T H Milhorat; M W Chou; E M Trinidad; R W Kula; M Mandell; C Wolpert; M C Speer
Journal:  Neurosurgery       Date:  1999-05       Impact factor: 4.654

2.  Asymptomatic Chiari Type I malformations identified on magnetic resonance imaging.

Authors:  J Meadows; M Kraut; M Guarnieri; R I Haroun; B S Carson
Journal:  J Neurosurg       Date:  2000-06       Impact factor: 5.115

3.  Ordered subset analysis in genetic linkage mapping of complex traits.

Authors:  Elizabeth R Hauser; Richard M Watanabe; William L Duren; Meredyth P Bass; Carl D Langefeld; Michael Boehnke
Journal:  Genet Epidemiol       Date:  2004-07       Impact factor: 2.135

4.  Significance of cerebellar tonsillar position on MR.

Authors:  A J Barkovich; F J Wippold; J L Sherman; C M Citrin
Journal:  AJNR Am J Neuroradiol       Date:  1986 Sep-Oct       Impact factor: 3.825

5.  Morphogenesis of experimentally induced Arnold--Chiari malformation.

Authors:  M Marin-Padilla; T M Marin-Padilla
Journal:  J Neurol Sci       Date:  1981-04       Impact factor: 3.181

Review 6.  The endophenotype concept in psychiatry: etymology and strategic intentions.

Authors:  Irving I Gottesman; Todd D Gould
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

7.  Position of cerebellar tonsils in the normal population and in patients with Chiari malformation: a quantitative approach with MR imaging.

Authors:  A O Aboulezz; K Sartor; C A Geyer; M H Gado
Journal:  J Comput Assist Tomogr       Date:  1985 Nov-Dec       Impact factor: 1.826

8.  Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9.

Authors:  Masanao Tsuda; Shigeru Takahashi; Yuji Takahashi; Hiroshi Asahara
Journal:  J Biol Chem       Date:  2003-05-05       Impact factor: 5.157

9.  Genetic basis for systems of skeletal quantitative traits: principal component analysis of the canid skeleton.

Authors:  Kevin Chase; David R Carrier; Frederick R Adler; Tyler Jarvik; Elaine A Ostrander; Travis D Lorentzen; Karl G Lark
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-11       Impact factor: 11.205

10.  The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription.

Authors:  Claudine G James; Anita Woods; T Michael Underhill; Frank Beier
Journal:  BMC Mol Biol       Date:  2006-09-19       Impact factor: 2.946

View more
  11 in total

1.  Small posterior fossa in Chiari I malformation affected families is significantly linked to 1q43-44 and 12q23-24.11 using whole exome sequencing.

Authors:  Anthony M Musolf; Winson S C Ho; Kyle A Long; Zhengping Zhuang; Davis P Argersinger; Haiming Sun; Bilal A Moiz; Claire L Simpson; Elena G Mendelevich; Enver I Bogdanov; Joan E Bailey-Wilson; John D Heiss
Journal:  Eur J Hum Genet       Date:  2019-06-21       Impact factor: 4.246

2.  Exome sequencing of two Italian pedigrees with non-isolated Chiari malformation type I reveals candidate genes for cranio-facial development.

Authors:  Elisa Merello; Lorenzo Tattini; Alberto Magi; Andrea Accogli; Gianluca Piatelli; Marco Pavanello; Domenico Tortora; Armando Cama; Zoha Kibar; Valeria Capra; Patrizia De Marco
Journal:  Eur J Hum Genet       Date:  2017-05-17       Impact factor: 4.246

3.  Epidemiology of Symptomatic Chiari Malformation in Tatarstan: Regional and Ethnic Differences in Prevalence.

Authors:  Enver I Bogdanov; Aisylu T Faizutdinova; Elena G Mendelevich; Alexey S Sozinov; John D Heiss
Journal:  Neurosurgery       Date:  2019-05-01       Impact factor: 4.654

4.  Neurologic involvement in patients with atypical Chediak-Higashi disease.

Authors:  Wendy J Introne; Wendy Westbroek; Andrew R Cullinane; Catherine A Groden; Vikas Bhambhani; Gretchen A Golas; Eva H Baker; Tanya J Lehky; Joseph Snow; Shira G Ziegler; David R Adams; Heidi M Dorward; Richard A Hess; Marjan Huizing; William A Gahl; Camilo Toro
Journal:  Neurology       Date:  2016-03-04       Impact factor: 9.910

5.  Chiari malformation type I: what information from the genetics?

Authors:  Valeria Capra; Michele Iacomino; Andrea Accogli; Marco Pavanello; Federico Zara; Armando Cama; Patrizia De Marco
Journal:  Childs Nerv Syst       Date:  2019-08-05       Impact factor: 1.475

Review 6.  Is there a morphometric cause of Chiari malformation type I? Analysis of existing literature.

Authors:  William H Shuman; Aislyn DiRisio; Alejandro Carrasquilla; Colin D Lamb; Addison Quinones; Aymeric Pionteck; Yang Yang; Mehmet Kurt; Raj K Shrivastava
Journal:  Neurosurg Rev       Date:  2021-07-13       Impact factor: 3.042

7.  Joint eQTL assessment of whole blood and dura mater tissue from individuals with Chiari type I malformation.

Authors:  Eric F Lock; Karen L Soldano; Melanie E Garrett; Heidi Cope; Christina A Markunas; Herbert Fuchs; Gerald Grant; David B Dunson; Simon G Gregory; Allison E Ashley-Koch
Journal:  BMC Genomics       Date:  2015-01-22       Impact factor: 3.969

8.  Rare functional genetic variants in COL7A1, COL6A5, COL1A2 and COL5A2 frequently occur in Chiari Malformation Type 1.

Authors:  Aintzane Urbizu; Melanie E Garrett; Karen Soldano; Oliver Drechsel; Dorothy Loth; Anna Marcé-Grau; Olga Mestres I Soler; Maria A Poca; Stephan Ossowski; Alfons Macaya; Francis Loth; Rick Labuda; Allison Ashley-Koch
Journal:  PLoS One       Date:  2021-05-11       Impact factor: 3.240

Review 9.  Functional and morphological changes in hypoplasic posterior fossa.

Authors:  Federico Bianchi; Alberto Benato; Paolo Frassanito; Gianpiero Tamburrini; Luca Massimi
Journal:  Childs Nerv Syst       Date:  2021-06-25       Impact factor: 1.475

10.  Identification of Chiari Type I Malformation subtypes using whole genome expression profiles and cranial base morphometrics.

Authors:  Christina A Markunas; Eric Lock; Karen Soldano; Heidi Cope; Chien-Kuang C Ding; David S Enterline; Gerald Grant; Herbert Fuchs; Allison E Ashley-Koch; Simon G Gregory
Journal:  BMC Med Genomics       Date:  2014-06-25       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.